AI-generated summary
The authors studied R6/2 transgenic mice, a model of Huntington's disease, kept under long-day (16 h light) or short-day (8 h light) photoperiods. They report that long-day exposure improved survival by 2.4 weeks and nocturnality, while short-day exposure reduced survival. The study was done in mice, so findings may not transfer directly to patients.
- Who or what was studied
- Female R6/2 transgenic mice, a mouse model of Huntington's disease, compared with wild-type mice
- Limits stated in the abstract
- The study was conducted in a transgenic mouse model and the abstract does not report human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.